Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.50797341 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.50797341 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.82930692 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.54364674 |
5 | negative regulation of cell killing (GO:0031342) | 4.22615538 |
6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.22615538 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.21843258 |
8 | positive thymic T cell selection (GO:0045059) | 3.89956195 |
9 | regulation of gamma-delta T cell activation (GO:0046643) | 3.79858844 |
10 | detection of other organism (GO:0098543) | 3.66931718 |
11 | detection of bacterium (GO:0016045) | 3.57206433 |
12 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.53078868 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.47478918 |
14 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39229137 |
15 | positive regulation of histone deacetylation (GO:0031065) | 3.39196737 |
16 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.38999889 |
17 | macrophage activation involved in immune response (GO:0002281) | 3.35678690 |
18 | detection of external biotic stimulus (GO:0098581) | 3.28641189 |
19 | response to peptidoglycan (GO:0032494) | 3.25601433 |
20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.24245356 |
21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22444783 |
22 | neutrophil activation involved in immune response (GO:0002283) | 3.21796887 |
23 | detection of molecule of bacterial origin (GO:0032490) | 3.18471898 |
24 | protein localization to endosome (GO:0036010) | 3.13480754 |
25 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.11977411 |
26 | thymic T cell selection (GO:0045061) | 3.10307740 |
27 | leukocyte aggregation (GO:0070486) | 3.08938057 |
28 | COPI coating of Golgi vesicle (GO:0048205) | 3.07795794 |
29 | Golgi transport vesicle coating (GO:0048200) | 3.07795794 |
30 | tolerance induction (GO:0002507) | 3.03412151 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01590365 |
32 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.00159981 |
33 | response to laminar fluid shear stress (GO:0034616) | 2.93833856 |
34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81705409 |
35 | response to host (GO:0075136) | 2.81705409 |
36 | response to host defenses (GO:0052200) | 2.81705409 |
37 | negative thymic T cell selection (GO:0045060) | 2.80875611 |
38 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80153143 |
39 | positive regulation of lamellipodium assembly (GO:0010592) | 2.79240142 |
40 | negative T cell selection (GO:0043383) | 2.76942954 |
41 | detection of biotic stimulus (GO:0009595) | 2.75683705 |
42 | cellular extravasation (GO:0045123) | 2.75264924 |
43 | positive T cell selection (GO:0043368) | 2.75049755 |
44 | response to interleukin-15 (GO:0070672) | 2.74098965 |
45 | hepatocyte apoptotic process (GO:0097284) | 2.73684204 |
46 | response to host immune response (GO:0052572) | 2.70701483 |
47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70701483 |
48 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70556501 |
49 | barbed-end actin filament capping (GO:0051016) | 2.69855863 |
50 | regulation of T cell tolerance induction (GO:0002664) | 2.67590743 |
51 | natural killer cell differentiation (GO:0001779) | 2.66363514 |
52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66344426 |
53 | leukocyte cell-cell adhesion (GO:0007159) | 2.66311847 |
54 | germinal center formation (GO:0002467) | 2.65341165 |
55 | apoptotic cell clearance (GO:0043277) | 2.64090559 |
56 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.63255121 |
57 | morphogenesis of an endothelium (GO:0003159) | 2.62974464 |
58 | endothelial tube morphogenesis (GO:0061154) | 2.62974464 |
59 | T cell selection (GO:0045058) | 2.61638265 |
60 | positive regulation of protein deacetylation (GO:0090312) | 2.61613039 |
61 | regulation of leukocyte degranulation (GO:0043300) | 2.61158204 |
62 | stress fiber assembly (GO:0043149) | 2.59057634 |
63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58595332 |
64 | growth hormone receptor signaling pathway (GO:0060396) | 2.58291740 |
65 | response to type I interferon (GO:0034340) | 2.57003304 |
66 | positive regulation of lamellipodium organization (GO:1902745) | 2.55817052 |
67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.55791526 |
68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55160262 |
69 | hypotonic response (GO:0006971) | 2.54391347 |
70 | pentose-phosphate shunt (GO:0006098) | 2.54166120 |
71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.52726598 |
72 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52661049 |
73 | neutrophil activation (GO:0042119) | 2.52651050 |
74 | positive regulation of tolerance induction (GO:0002645) | 2.52531155 |
75 | regulation of mast cell degranulation (GO:0043304) | 2.51859327 |
76 | positive regulation of receptor recycling (GO:0001921) | 2.51835291 |
77 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.51278459 |
78 | NIK/NF-kappaB signaling (GO:0038061) | 2.50413068 |
79 | response to muramyl dipeptide (GO:0032495) | 2.49350930 |
80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.48962744 |
81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.47503882 |
82 | positive regulation of B cell differentiation (GO:0045579) | 2.47410078 |
83 | type I interferon signaling pathway (GO:0060337) | 2.47291501 |
84 | cellular response to type I interferon (GO:0071357) | 2.47291501 |
85 | regulation of B cell differentiation (GO:0045577) | 2.47231040 |
86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.46935333 |
87 | regulation of response to interferon-gamma (GO:0060330) | 2.46323558 |
88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.45813632 |
89 | negative regulation of type 2 immune response (GO:0002829) | 2.45663830 |
90 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.45537906 |
91 | granulocyte activation (GO:0036230) | 2.44378796 |
92 | skin morphogenesis (GO:0043589) | 2.43047568 |
93 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.42290674 |
94 | valine metabolic process (GO:0006573) | 2.40903670 |
95 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.37913871 |
96 | T cell apoptotic process (GO:0070231) | 2.37668558 |
97 | regulation of extracellular matrix disassembly (GO:0010715) | 2.37118204 |
98 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.36821560 |
99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36106702 |
100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36106702 |
101 | modulation by symbiont of host immune response (GO:0052553) | 2.36106702 |
102 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36106702 |
103 | modulation by symbiont of host defense response (GO:0052031) | 2.36106702 |
104 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36106702 |
105 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.35565051 |
106 | mannose metabolic process (GO:0006013) | 2.35259518 |
107 | negative regulation of interleukin-12 production (GO:0032695) | 2.34652153 |
108 | regulation of cholesterol homeostasis (GO:2000188) | 2.34236239 |
109 | actin nucleation (GO:0045010) | 2.34101779 |
110 | regulation of cholesterol storage (GO:0010885) | 2.33383096 |
111 | establishment of endothelial barrier (GO:0061028) | 2.33116502 |
112 | negative regulation of phagocytosis (GO:0050765) | 2.33058457 |
113 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.31204677 |
114 | regulation of natural killer cell differentiation (GO:0032823) | 2.30871998 |
115 | regulation of macrophage cytokine production (GO:0010935) | 2.30341157 |
116 | regulation of necroptotic process (GO:0060544) | 2.29582362 |
117 | negative regulation of interleukin-6 production (GO:0032715) | 2.29499201 |
118 | T cell migration (GO:0072678) | 2.29199233 |
119 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.29137092 |
120 | respiratory burst (GO:0045730) | 2.28692444 |
121 | B cell receptor signaling pathway (GO:0050853) | 2.28162866 |
122 | macrophage activation (GO:0042116) | 2.27929435 |
123 | T cell costimulation (GO:0031295) | 2.27688016 |
124 | immunoglobulin mediated immune response (GO:0016064) | 2.27339873 |
125 | lymphocyte apoptotic process (GO:0070227) | 2.26875815 |
126 | regulation of type 2 immune response (GO:0002828) | 2.26853974 |
127 | low-density lipoprotein particle clearance (GO:0034383) | 2.25666452 |
128 | cellular response to growth hormone stimulus (GO:0071378) | 2.25140944 |
129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.24967874 |
130 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.24437886 |
131 | response to interferon-alpha (GO:0035455) | 2.24028939 |
132 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.23699905 |
133 | maternal placenta development (GO:0001893) | 2.23503401 |
134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.23005554 |
135 | positive regulation of nuclease activity (GO:0032075) | 2.22920091 |
136 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.22878733 |
137 | lymphocyte costimulation (GO:0031294) | 2.22190830 |
138 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.21784735 |
139 | pinocytosis (GO:0006907) | 2.21631550 |
140 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21559429 |
141 | negative regulation of stress fiber assembly (GO:0051497) | 2.21061481 |
142 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.20998225 |
143 | tricarboxylic acid metabolic process (GO:0072350) | 2.20966079 |
144 | interferon-gamma production (GO:0032609) | 2.20774027 |
145 | hemidesmosome assembly (GO:0031581) | 2.20723206 |
146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.20259440 |
147 | protein retention in ER lumen (GO:0006621) | 2.19996784 |
148 | regulation of tolerance induction (GO:0002643) | 2.19791282 |
149 | negative regulation of fatty acid transport (GO:2000192) | 2.19669796 |
150 | modulation by symbiont of host cellular process (GO:0044068) | 2.19320415 |
151 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.19184152 |
152 | negative regulation of bone resorption (GO:0045779) | 2.19132765 |
153 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.18348710 |
154 | positive regulation of extracellular matrix organization (GO:1903055) | 2.18220843 |
155 | cell-substrate junction assembly (GO:0007044) | 2.17864041 |
156 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.17668636 |
157 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.17566234 |
158 | positive regulation of interferon-alpha production (GO:0032727) | 2.16997206 |
159 | angiogenesis involved in wound healing (GO:0060055) | 2.16965205 |
160 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.16216630 |
161 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.14670569 |
162 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.14427059 |
163 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.14304863 |
164 | negative regulation of viral entry into host cell (GO:0046597) | 2.13954580 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.56820139 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24146732 |
3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.04579104 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02253857 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.85490762 |
6 | MYC_22102868_ChIP-Seq_BL_Human | 2.81906353 |
7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50647277 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44346745 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.39201737 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26073543 |
11 | MAF_26560356_Chip-Seq_TH1_Human | 2.17586339 |
12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14625545 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08555519 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.07374944 |
15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05565952 |
16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01212961 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99564504 |
18 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97760118 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97614315 |
20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95906731 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88886347 |
22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.86407962 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85088960 |
24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83770403 |
25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83697731 |
26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83620842 |
27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82818346 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 1.82656382 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.81386896 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80889801 |
31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80563859 |
32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80436446 |
33 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.78589826 |
34 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77364644 |
35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76735121 |
36 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75306283 |
37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74662013 |
38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72397235 |
39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68124557 |
40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65451151 |
41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.64347821 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63651133 |
43 | * MYB_26560356_Chip-Seq_TH1_Human | 1.63478741 |
44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.61955959 |
45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59206319 |
46 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58585881 |
47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58211585 |
48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57538626 |
49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56797021 |
50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56583477 |
51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53920457 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53708726 |
53 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53115479 |
54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53098693 |
55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50030898 |
56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.46411663 |
57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43788096 |
58 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.40811057 |
59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.40294914 |
60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39796084 |
61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.38509360 |
62 | MAF_26560356_Chip-Seq_TH2_Human | 1.38023635 |
63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35945311 |
64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34095602 |
65 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30941957 |
66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30276715 |
67 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.30165625 |
68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29896989 |
69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29234223 |
70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27639923 |
71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26325680 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25559353 |
73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25000103 |
74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24265411 |
75 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23285645 |
76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22826770 |
77 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18996612 |
78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18433688 |
79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18320911 |
80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18274576 |
81 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18137468 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17160264 |
83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16381495 |
84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14976389 |
85 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14789434 |
86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12988980 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12739124 |
88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12639871 |
89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11679992 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10944419 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09767736 |
92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09426987 |
93 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08804147 |
94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08776588 |
95 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08219324 |
96 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06600468 |
97 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06211685 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06090009 |
99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04350601 |
100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03675287 |
101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02987409 |
102 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02352787 |
103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01813667 |
104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01813667 |
105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01715272 |
106 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01628560 |
107 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01283382 |
108 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00676894 |
109 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00172892 |
110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98338695 |
111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97752975 |
112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97706696 |
113 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97268501 |
114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97214004 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96062110 |
116 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95948507 |
117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95710842 |
118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95372428 |
119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95099355 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003300_gastrointestinal_ulcer | 3.32622411 |
2 | MP0003303_peritoneal_inflammation | 2.49020944 |
3 | MP0003705_abnormal_hypodermis_morpholog | 2.43354471 |
4 | MP0000685_abnormal_immune_system | 2.41473272 |
5 | MP0003436_decreased_susceptibility_to | 2.22316430 |
6 | MP0010234_abnormal_vibrissa_follicle | 2.18093705 |
7 | MP0001835_abnormal_antigen_presentation | 2.16486048 |
8 | MP0005387_immune_system_phenotype | 2.14219520 |
9 | MP0001790_abnormal_immune_system | 2.14219520 |
10 | MP0004947_skin_inflammation | 2.04489388 |
11 | MP0003763_abnormal_thymus_physiology | 2.02386673 |
12 | MP0005451_abnormal_body_composition | 1.94659621 |
13 | MP0008260_abnormal_autophagy | 1.89348243 |
14 | MP0009840_abnormal_foam_cell | 1.89042120 |
15 | MP0001800_abnormal_humoral_immune | 1.87325579 |
16 | MP0010155_abnormal_intestine_physiology | 1.86907162 |
17 | MP0001873_stomach_inflammation | 1.86150551 |
18 | MP0003566_abnormal_cell_adhesion | 1.86143062 |
19 | MP0005058_abnormal_lysosome_morphology | 1.83422961 |
20 | MP0003724_increased_susceptibility_to | 1.83311046 |
21 | MP0010352_gastrointestinal_tract_polyps | 1.81599951 |
22 | MP0005000_abnormal_immune_tolerance | 1.79530271 |
23 | MP0002166_altered_tumor_susceptibility | 1.79313705 |
24 | MP0005671_abnormal_response_to | 1.77359874 |
25 | MP0008438_abnormal_cutaneous_collagen | 1.74037170 |
26 | MP0003866_abnormal_defecation | 1.73598731 |
27 | MP0003191_abnormal_cellular_cholesterol | 1.73450059 |
28 | MP0009785_altered_susceptibility_to | 1.73291442 |
29 | MP0006054_spinal_hemorrhage | 1.71077635 |
30 | MP0002452_abnormal_antigen_presenting | 1.69437564 |
31 | MP0005025_abnormal_response_to | 1.68713175 |
32 | MP0006082_CNS_inflammation | 1.64188094 |
33 | MP0004858_abnormal_nervous_system | 1.63978520 |
34 | MP0002723_abnormal_immune_serum | 1.60772656 |
35 | MP0009333_abnormal_splenocyte_physiolog | 1.60073138 |
36 | MP0002420_abnormal_adaptive_immunity | 1.57255704 |
37 | MP0001819_abnormal_immune_cell | 1.56570460 |
38 | MP0005464_abnormal_platelet_physiology | 1.54108265 |
39 | MP0001958_emphysema | 1.51409196 |
40 | MP0002405_respiratory_system_inflammati | 1.51384000 |
41 | MP0002933_joint_inflammation | 1.49612395 |
42 | MP0003183_abnormal_peptide_metabolism | 1.49586277 |
43 | MP0004510_myositis | 1.49030534 |
44 | MP0002419_abnormal_innate_immunity | 1.47441125 |
45 | MP0001533_abnormal_skeleton_physiology | 1.43756214 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.42368159 |
47 | MP0005023_abnormal_wound_healing | 1.41557745 |
48 | MP0001845_abnormal_inflammatory_respons | 1.40835109 |
49 | MP0002398_abnormal_bone_marrow | 1.39178570 |
50 | MP0005164_abnormal_response_to | 1.38002078 |
51 | MP0004272_abnormal_basement_membrane | 1.34078407 |
52 | MP0000716_abnormal_immune_system | 1.31116168 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.30607862 |
54 | MP0002148_abnormal_hypersensitivity_rea | 1.30393738 |
55 | MP0005390_skeleton_phenotype | 1.30025195 |
56 | MP0009278_abnormal_bone_marrow | 1.27412464 |
57 | MP0003279_aneurysm | 1.27044014 |
58 | MP0003075_altered_response_to | 1.26444125 |
59 | MP0002006_tumorigenesis | 1.25942632 |
60 | MP0009643_abnormal_urine_homeostasis | 1.25897063 |
61 | MP0005275_abnormal_skin_tensile | 1.24036673 |
62 | MP0000767_abnormal_smooth_muscle | 1.23974915 |
63 | MP0000689_abnormal_spleen_morphology | 1.22508241 |
64 | MP0005360_urolithiasis | 1.21940485 |
65 | MP0002722_abnormal_immune_system | 1.21816738 |
66 | MP0002396_abnormal_hematopoietic_system | 1.21466162 |
67 | MP0002877_abnormal_melanocyte_morpholog | 1.21360048 |
68 | MP0004883_abnormal_blood_vessel | 1.20397313 |
69 | MP0000490_abnormal_crypts_of | 1.19946327 |
70 | MP0000858_altered_metastatic_potential | 1.18487116 |
71 | MP0003453_abnormal_keratinocyte_physiol | 1.16435524 |
72 | MP0005409_darkened_coat_color | 1.14123340 |
73 | MP0005503_abnormal_tendon_morphology | 1.13909551 |
74 | MP0005257_abnormal_intraocular_pressure | 1.13313305 |
75 | MP0002429_abnormal_blood_cell | 1.13169735 |
76 | MP0001542_abnormal_bone_strength | 1.11169681 |
77 | MP0008469_abnormal_protein_level | 1.10207673 |
78 | MP0004185_abnormal_adipocyte_glucose | 1.09085621 |
79 | MP0005076_abnormal_cell_differentiation | 1.08274272 |
80 | MP0001853_heart_inflammation | 1.08005427 |
81 | MP0008004_abnormal_stomach_pH | 1.06469668 |
82 | MP0003045_fibrosis | 1.05459888 |
83 | MP0005397_hematopoietic_system_phenotyp | 1.03403852 |
84 | MP0001545_abnormal_hematopoietic_system | 1.03403852 |
85 | MP0002136_abnormal_kidney_physiology | 1.02465038 |
86 | MP0003091_abnormal_cell_migration | 1.02012283 |
87 | MP0004808_abnormal_hematopoietic_stem | 1.01801931 |
88 | MP0002998_abnormal_bone_remodeling | 1.01204826 |
89 | MP0008961_abnormal_basal_metabolism | 0.99810120 |
90 | MP0003172_abnormal_lysosome_physiology | 0.98860526 |
91 | MP0000604_amyloidosis | 0.98231196 |
92 | MP0005310_abnormal_salivary_gland | 0.97404527 |
93 | MP0000343_altered_response_to | 0.96170901 |
94 | MP0000703_abnormal_thymus_morphology | 0.96007868 |
95 | MP0002132_abnormal_respiratory_system | 0.95872020 |
96 | MP0000609_abnormal_liver_physiology | 0.95659419 |
97 | MP0003448_altered_tumor_morphology | 0.94693164 |
98 | MP0001851_eye_inflammation | 0.93283754 |
99 | MP0002060_abnormal_skin_morphology | 0.93170569 |
100 | MP0001666_abnormal_nutrient_absorption | 0.92922329 |
101 | MP0003329_amyloid_beta_deposits | 0.92285815 |
102 | MP0005666_abnormal_adipose_tissue | 0.88150996 |
103 | MP0001849_ear_inflammation | 0.87546591 |
104 | MP0004264_abnormal_extraembryonic_tissu | 0.87225752 |
105 | MP0000477_abnormal_intestine_morphology | 0.87013315 |
106 | MP0000678_abnormal_parathyroid_gland | 0.86820807 |
107 | MP0001663_abnormal_digestive_system | 0.86198894 |
108 | MP0004381_abnormal_hair_follicle | 0.84710193 |
109 | MP0002796_impaired_skin_barrier | 0.84568752 |
110 | MP0001216_abnormal_epidermal_layer | 0.83734131 |
111 | MP0009384_cardiac_valve_regurgitation | 0.82829689 |
112 | MP0010368_abnormal_lymphatic_system | 0.82594193 |
113 | MP0002896_abnormal_bone_mineralization | 0.81880878 |
114 | MP0000249_abnormal_blood_vessel | 0.80974456 |
115 | MP0003795_abnormal_bone_structure | 0.80605411 |
116 | MP0001879_abnormal_lymphatic_vessel | 0.80521613 |
117 | MP0003252_abnormal_bile_duct | 0.80487961 |
118 | MP0005083_abnormal_biliary_tract | 0.79746486 |
119 | MP0005166_decreased_susceptibility_to | 0.77572767 |
120 | MP0003828_pulmonary_edema | 0.77381926 |
121 | MP0005375_adipose_tissue_phenotype | 0.76069014 |
122 | MP0009764_decreased_sensitivity_to | 0.75699500 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Interstitial pulmonary disease (HP:0006530) | 3.51912014 |
2 | Abnormality of the nasal mucosa (HP:0000433) | 3.42951252 |
3 | Eczematoid dermatitis (HP:0000976) | 3.38743743 |
4 | Chronic otitis media (HP:0000389) | 3.33369271 |
5 | Nasal polyposis (HP:0100582) | 3.31677947 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03830867 |
7 | Vascular tortuosity (HP:0004948) | 2.96989235 |
8 | Dysostosis multiplex (HP:0000943) | 2.88045785 |
9 | Cerebral aneurysm (HP:0004944) | 2.87552251 |
10 | Arterial tortuosity (HP:0005116) | 2.84882248 |
11 | Recurrent bronchitis (HP:0002837) | 2.80596450 |
12 | Autoimmune thrombocytopenia (HP:0001973) | 2.75123203 |
13 | IgM deficiency (HP:0002850) | 2.72506730 |
14 | Vacuolated lymphocytes (HP:0001922) | 2.72280655 |
15 | Pustule (HP:0200039) | 2.66955145 |
16 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66919006 |
17 | Aortic aneurysm (HP:0004942) | 2.65253077 |
18 | Mucopolysacchariduria (HP:0008155) | 2.65141055 |
19 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65141055 |
20 | Gingivitis (HP:0000230) | 2.63176386 |
21 | Recurrent fungal infections (HP:0002841) | 2.61021759 |
22 | Gastrointestinal infarctions (HP:0005244) | 2.60599577 |
23 | Recurrent viral infections (HP:0004429) | 2.60485394 |
24 | Spontaneous hematomas (HP:0007420) | 2.59302515 |
25 | Increased IgE level (HP:0003212) | 2.57150463 |
26 | Gastrointestinal inflammation (HP:0004386) | 2.56873151 |
27 | Protrusio acetabuli (HP:0003179) | 2.54999579 |
28 | Inflammation of the large intestine (HP:0002037) | 2.54847013 |
29 | Hematochezia (HP:0002573) | 2.50798672 |
30 | Increased connective tissue (HP:0009025) | 2.45770043 |
31 | Colitis (HP:0002583) | 2.44417728 |
32 | Optic neuritis (HP:0100653) | 2.43935736 |
33 | Retrobulbar optic neuritis (HP:0100654) | 2.43935736 |
34 | Cellulitis (HP:0100658) | 2.43105551 |
35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39841902 |
36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39841902 |
37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39841902 |
38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.39108742 |
39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.39108742 |
40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.39108742 |
41 | Emphysema (HP:0002097) | 2.38953979 |
42 | Myositis (HP:0100614) | 2.34758047 |
43 | Polycythemia (HP:0001901) | 2.31498211 |
44 | Amyloidosis (HP:0011034) | 2.31269684 |
45 | Aortic dissection (HP:0002647) | 2.30925166 |
46 | Thin bony cortex (HP:0002753) | 2.29884216 |
47 | Spondylolisthesis (HP:0003302) | 2.29772331 |
48 | Cervical subluxation (HP:0003308) | 2.29307280 |
49 | Fragile skin (HP:0001030) | 2.28292483 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.27850191 |
51 | Peritonitis (HP:0002586) | 2.25746440 |
52 | Recurrent abscess formation (HP:0002722) | 2.22973940 |
53 | Increased density of long bones (HP:0006392) | 2.22496407 |
54 | Verrucae (HP:0200043) | 2.18663165 |
55 | Papilloma (HP:0012740) | 2.18663165 |
56 | Broad face (HP:0000283) | 2.18038411 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.17643143 |
58 | Obstructive lung disease (HP:0006536) | 2.17643143 |
59 | Hemorrhage of the eye (HP:0011885) | 2.14012126 |
60 | Blue sclerae (HP:0000592) | 2.13703764 |
61 | Right ventricular cardiomyopathy (HP:0011663) | 2.13403565 |
62 | Premature rupture of membranes (HP:0001788) | 2.12816624 |
63 | Mediastinal lymphadenopathy (HP:0100721) | 2.12250005 |
64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.11568765 |
65 | Thrombocytosis (HP:0001894) | 2.11560776 |
66 | T lymphocytopenia (HP:0005403) | 2.11109873 |
67 | Impaired platelet aggregation (HP:0003540) | 2.10364775 |
68 | Abnormal platelet function (HP:0011869) | 2.10364775 |
69 | Urticaria (HP:0001025) | 2.10052109 |
70 | Abnormality of macrophages (HP:0004311) | 2.08485764 |
71 | Malnutrition (HP:0004395) | 2.08329644 |
72 | Myocardial infarction (HP:0001658) | 2.08322483 |
73 | Systemic lupus erythematosus (HP:0002725) | 2.07948230 |
74 | Ankle contracture (HP:0006466) | 2.06855567 |
75 | Increased cerebral lipofuscin (HP:0011813) | 2.06849900 |
76 | Abnormality of T cells (HP:0002843) | 2.06043693 |
77 | Gastrointestinal stroma tumor (HP:0100723) | 2.04670108 |
78 | Abnormality of T cell physiology (HP:0011840) | 2.03936693 |
79 | Aneurysm (HP:0002617) | 2.03432815 |
80 | Abnormality of T cell number (HP:0011839) | 2.02569762 |
81 | Asymmetric septal hypertrophy (HP:0001670) | 2.00638955 |
82 | Gingival bleeding (HP:0000225) | 2.00512689 |
83 | Petechiae (HP:0000967) | 1.98081573 |
84 | Prolonged bleeding time (HP:0003010) | 1.97147715 |
85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96926683 |
86 | Osteolytic defects of the hand bones (HP:0009699) | 1.96926683 |
87 | Wormian bones (HP:0002645) | 1.95384763 |
88 | Obstructive sleep apnea (HP:0002870) | 1.94893214 |
89 | Abnormality of the peritoneum (HP:0002585) | 1.94064140 |
90 | Recurrent bacterial skin infections (HP:0005406) | 1.93914035 |
91 | Fatigue (HP:0012378) | 1.92517458 |
92 | Dilatation of the ascending aorta (HP:0005111) | 1.91578162 |
93 | Vasculitis (HP:0002633) | 1.90410673 |
94 | Genu recurvatum (HP:0002816) | 1.90155628 |
95 | Distal lower limb muscle weakness (HP:0009053) | 1.89872082 |
96 | Keratoconjunctivitis sicca (HP:0001097) | 1.88772021 |
97 | Panhypogammaglobulinemia (HP:0003139) | 1.88479636 |
98 | Esophageal varix (HP:0002040) | 1.87769074 |
99 | Flat acetabular roof (HP:0003180) | 1.86449933 |
100 | Lymphopenia (HP:0001888) | 1.85858374 |
101 | Purpura (HP:0000979) | 1.85540904 |
102 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85126122 |
103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84015935 |
104 | Atrophic scars (HP:0001075) | 1.83983793 |
105 | Pulmonary infiltrates (HP:0002113) | 1.83509563 |
106 | Arterial thrombosis (HP:0004420) | 1.82546145 |
107 | Ulnar bowing (HP:0003031) | 1.82294993 |
108 | Slender build (HP:0001533) | 1.81171896 |
109 | Mitral valve prolapse (HP:0001634) | 1.81027240 |
110 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80773996 |
111 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80773996 |
112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.79961360 |
113 | Abnormal platelet volume (HP:0011876) | 1.78936616 |
114 | Vertebral compression fractures (HP:0002953) | 1.76447414 |
115 | Persistence of primary teeth (HP:0006335) | 1.75097679 |
116 | Epistaxis (HP:0000421) | 1.74767365 |
117 | Bladder diverticulum (HP:0000015) | 1.74696961 |
118 | Broad metatarsal (HP:0001783) | 1.73924925 |
119 | Increased serum ferritin (HP:0003281) | 1.73339475 |
120 | Restrictive lung disease (HP:0002091) | 1.73210359 |
121 | Episodic fever (HP:0001954) | 1.73169861 |
122 | Recurrent skin infections (HP:0001581) | 1.73163032 |
123 | Osteomyelitis (HP:0002754) | 1.73035777 |
124 | Chronic diarrhea (HP:0002028) | 1.72627443 |
125 | Mitral regurgitation (HP:0001653) | 1.72392051 |
126 | Hypochromic anemia (HP:0001931) | 1.71172300 |
127 | Spinal rigidity (HP:0003306) | 1.70971052 |
128 | Disproportionate tall stature (HP:0001519) | 1.70778641 |
129 | Loss of speech (HP:0002371) | 1.70551034 |
130 | Premature loss of primary teeth (HP:0006323) | 1.70432178 |
131 | Hemoptysis (HP:0002105) | 1.70091861 |
132 | Joint stiffness (HP:0001387) | 1.70017541 |
133 | Abnormality of the pericardium (HP:0001697) | 1.69921861 |
134 | Stomatitis (HP:0010280) | 1.69892299 |
135 | Frequent falls (HP:0002359) | 1.69314876 |
136 | Skin ulcer (HP:0200042) | 1.69108459 |
137 | Chest pain (HP:0100749) | 1.68432150 |
138 | Orchitis (HP:0100796) | 1.67963759 |
139 | Abnormality of the fingertips (HP:0001211) | 1.67953004 |
140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67929974 |
141 | Autoimmune hemolytic anemia (HP:0001890) | 1.67902276 |
142 | Ectopia lentis (HP:0001083) | 1.66691480 |
143 | Agammaglobulinemia (HP:0004432) | 1.66134359 |
144 | Hyperactive renin-angiotensin system (HP:0000841) | 1.65356164 |
145 | Mesangial abnormality (HP:0001966) | 1.65111015 |
146 | Periodontitis (HP:0000704) | 1.64877364 |
147 | Meningitis (HP:0001287) | 1.64797029 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.08317475 |
2 | MAP4K1 | 3.81504990 |
3 | ERN1 | 3.80662926 |
4 | PKN2 | 2.73592808 |
5 | PRPF4B | 2.47055439 |
6 | RIPK4 | 2.45635875 |
7 | EEF2K | 2.44504508 |
8 | MAP3K10 | 2.42718881 |
9 | EPHB1 | 2.17423647 |
10 | JAK3 | 2.16791670 |
11 | STK10 | 2.11761540 |
12 | LRRK2 | 2.07239461 |
13 | ZAP70 | 2.03370517 |
14 | FGFR4 | 1.99568236 |
15 | TBK1 | 1.88936835 |
16 | TYK2 | 1.88415552 |
17 | TGFBR2 | 1.80593051 |
18 | PTK6 | 1.78792532 |
19 | TTN | 1.74718267 |
20 | SMG1 | 1.73855309 |
21 | KDR | 1.68315836 |
22 | SIK1 | 1.65547855 |
23 | BLK | 1.56302556 |
24 | GRK6 | 1.53125732 |
25 | RIPK1 | 1.47410742 |
26 | JAK1 | 1.42984588 |
27 | NME2 | 1.39830827 |
28 | MAP2K3 | 1.38456055 |
29 | BTK | 1.34007161 |
30 | ITK | 1.33314910 |
31 | IKBKE | 1.30402923 |
32 | CDC42BPA | 1.30305415 |
33 | CSK | 1.29960186 |
34 | TAOK2 | 1.28139950 |
35 | TAOK3 | 1.25000604 |
36 | EPHA3 | 1.24004630 |
37 | FLT3 | 1.22621693 |
38 | KIT | 1.22390195 |
39 | MAP3K14 | 1.22257128 |
40 | KSR2 | 1.18488418 |
41 | MST4 | 1.16623970 |
42 | RPS6KA4 | 1.14867607 |
43 | MAP3K3 | 1.14234129 |
44 | TXK | 1.13801171 |
45 | ICK | 1.11739754 |
46 | TNK2 | 1.08550738 |
47 | MARK2 | 1.05488156 |
48 | SCYL2 | 1.03429919 |
49 | STK38 | 1.03071921 |
50 | NLK | 1.02995074 |
51 | MAP3K6 | 1.02476123 |
52 | MAP3K11 | 1.01881741 |
53 | FES | 0.99624490 |
54 | TAOK1 | 0.97875451 |
55 | SIK3 | 0.97315580 |
56 | MAP2K2 | 0.96050995 |
57 | MAP3K7 | 0.95429443 |
58 | HCK | 0.94280379 |
59 | FGFR3 | 0.93282762 |
60 | PDPK1 | 0.91972097 |
61 | CSF1R | 0.90892015 |
62 | PIM2 | 0.90544495 |
63 | MYLK | 0.90509186 |
64 | MARK3 | 0.88990205 |
65 | LCK | 0.87581130 |
66 | TESK2 | 0.86500553 |
67 | PAK4 | 0.85664266 |
68 | DDR2 | 0.84420609 |
69 | SYK | 0.83769742 |
70 | JAK2 | 0.83367106 |
71 | FGR | 0.82326890 |
72 | IKBKB | 0.80181714 |
73 | TESK1 | 0.79994851 |
74 | MAP3K2 | 0.79986884 |
75 | TEC | 0.79914872 |
76 | RPS6KA2 | 0.79803765 |
77 | IRAK3 | 0.79564413 |
78 | PTK2 | 0.78744812 |
79 | CHUK | 0.76769039 |
80 | PDGFRA | 0.76515172 |
81 | DMPK | 0.73243267 |
82 | PRKG2 | 0.72432573 |
83 | PRKCH | 0.71266631 |
84 | LMTK2 | 0.70881561 |
85 | PTK2B | 0.70129571 |
86 | BMX | 0.68141372 |
87 | MAPKAPK3 | 0.67722810 |
88 | MST1R | 0.66770219 |
89 | MAPK7 | 0.66750021 |
90 | MAP3K1 | 0.66632638 |
91 | CDK12 | 0.66263483 |
92 | NEK9 | 0.65835319 |
93 | PIM1 | 0.65409617 |
94 | MAP3K8 | 0.64881118 |
95 | RPS6KL1 | 0.64545862 |
96 | RPS6KC1 | 0.64545862 |
97 | EPHB2 | 0.63890719 |
98 | PDK1 | 0.63126480 |
99 | HIPK2 | 0.62355559 |
100 | IRAK1 | 0.61755041 |
101 | IRAK2 | 0.58132256 |
102 | PRKD2 | 0.57881035 |
103 | TGFBR1 | 0.57561980 |
104 | MOS | 0.54972341 |
105 | ILK | 0.54018458 |
106 | PDGFRB | 0.53649277 |
107 | RPS6KB2 | 0.53034310 |
108 | MAPK15 | 0.51993412 |
109 | TRPM7 | 0.50141394 |
110 | PAK2 | 0.49899327 |
111 | TIE1 | 0.49799522 |
112 | CDK6 | 0.48850800 |
113 | RPS6KA6 | 0.48694426 |
114 | MAPK12 | 0.47731620 |
115 | YES1 | 0.47248972 |
116 | EPHA2 | 0.46864291 |
117 | MAP3K13 | 0.46783788 |
118 | MATK | 0.46209117 |
119 | FYN | 0.45581734 |
120 | MET | 0.45035435 |
121 | ARAF | 0.44790084 |
122 | MAPKAPK2 | 0.44627995 |
123 | DYRK1B | 0.44390858 |
124 | PRKD1 | 0.42629537 |
125 | CDK4 | 0.42448872 |
126 | LYN | 0.41231407 |
127 | MTOR | 0.40141144 |
128 | CAMK1D | 0.40108014 |
129 | RET | 0.38710008 |
130 | BCKDK | 0.38463628 |
131 | FRK | 0.37961335 |
132 | MAPK11 | 0.36707082 |
133 | ALK | 0.35469185 |
134 | IRAK4 | 0.35360740 |
135 | PRKCQ | 0.34400879 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.67595593 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.21961221 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06673393 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96707649 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.91952205 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.84608635 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80147008 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.79466659 |
9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.76745144 |
10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74800007 |
11 | Measles_Homo sapiens_hsa05162 | 1.64260294 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.61334818 |
13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57542969 |
14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56646547 |
15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56293253 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54158201 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51760887 |
18 | Lysosome_Homo sapiens_hsa04142 | 1.47568693 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40957973 |
20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40883890 |
21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40159089 |
22 | Shigellosis_Homo sapiens_hsa05131 | 1.38457519 |
23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36857560 |
24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35388302 |
25 | Malaria_Homo sapiens_hsa05144 | 1.33668536 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30920643 |
27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29407453 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27926595 |
29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25478591 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23602205 |
31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22829685 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.21497671 |
33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20967977 |
34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19413220 |
35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.18655734 |
36 | Legionellosis_Homo sapiens_hsa05134 | 1.17579754 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16885188 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.15741624 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.14502428 |
40 | Phagosome_Homo sapiens_hsa04145 | 1.13144090 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 1.11294738 |
42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06341119 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.05707722 |
44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05414431 |
45 | Platelet activation_Homo sapiens_hsa04611 | 1.05390521 |
46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05096634 |
47 | Amoebiasis_Homo sapiens_hsa05146 | 1.04603960 |
48 | Focal adhesion_Homo sapiens_hsa04510 | 1.04199189 |
49 | Influenza A_Homo sapiens_hsa05164 | 1.03328424 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02774306 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 1.00157306 |
52 | Salmonella infection_Homo sapiens_hsa05132 | 0.97358612 |
53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96462592 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93968530 |
55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93429289 |
56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91769225 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90256163 |
58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90115792 |
59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87646891 |
60 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87612531 |
61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87440314 |
62 | Bladder cancer_Homo sapiens_hsa05219 | 0.86436162 |
63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84995097 |
64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84556146 |
65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83797473 |
66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83020647 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82648533 |
68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78574623 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77689839 |
70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77500881 |
71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76752296 |
72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76258305 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74581925 |
74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73562607 |
75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73388801 |
76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72679472 |
77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72507456 |
78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71136586 |
79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71040460 |
80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70843773 |
81 | Adherens junction_Homo sapiens_hsa04520 | 0.70455848 |
82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69109914 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.69086644 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68953984 |
85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67617563 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67232048 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65910426 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65555837 |
89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65139417 |
90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65138536 |
91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63382750 |
92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63095439 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61405399 |
94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60536806 |
95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60339652 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60176626 |
97 | ABC transporters_Homo sapiens_hsa02010 | 0.59637797 |
98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58305231 |
99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57897373 |
100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57712360 |
101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57659239 |
102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57545897 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57190534 |
104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56851322 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.56530186 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56311361 |
107 | Allograft rejection_Homo sapiens_hsa05330 | 0.56107501 |
108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54958544 |
109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54587143 |
110 | Glioma_Homo sapiens_hsa05214 | 0.53258885 |
111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52746482 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52099105 |
113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51710521 |
114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51487659 |
115 | Lysine degradation_Homo sapiens_hsa00310 | 0.51380634 |
116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51323733 |
117 | Bile secretion_Homo sapiens_hsa04976 | 0.51247276 |
118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50270829 |
119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48888856 |
120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48739474 |
121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46070815 |
122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44470360 |
123 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43578700 |
124 | Prostate cancer_Homo sapiens_hsa05215 | 0.43576152 |
125 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43149923 |
126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42708478 |